iBio, Inc. financial statements
iBio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 100K | 10-K |
| Net income | −USD 33.04M | 10-K |
| Cash and equivalents | USD 56.4M | 10-Q |
| Total debt | USD 2.2M | EODHD |